In a recent study, the dual inhibition of VEGFR and angiopoietin-2 in two orthotopic models of GBM, improved mice survival by reducing cell growth, increasing cell necrosis and promoting morphological normalization of the vasculature [31]. The gene discussed is ANGPT2; the disease is glioblastoma.